A major goal of this laboratory is to understand the molecular mechanisms by which the nuclear hormone receptor peroxisome proliferator-activated receptor ? (PPAR?) controls adipogenesis and mediates antidiabetic effects of thiazolidinedione (TZD) drugs that improve insulin sensitivity but cause unwanted side effects. We hypothesize that target gene- and tissue- selective modulation of gene expression by PPAR? are dictated by different modes of PPAR? binding and synergy between PPAR? and cooperating transcription factors.
Specific Aim 1 is to determine the direct transcriptional effect of TZDs in adipocytes and their relation to PPAR? binding on a genome-wide scale. We hypothesize that the direct effects of TZDs on transcription cannot be predicted from transcriptomic analysis. Preliminary Global Run-On sequencing (GRO-seq) results demonstrate the feasibility of measuring nascent transcripts in adipocytes on a genome-wide scale.
Specific Aim 2 is to delineate the adipocyte epigenome and corepressor cistromes, and their relation to PPAR? binding and the effects of TZD treatment on a genome-wide scale. We hypothesize that TZD treatment of adipocytes alters coregulator recruitment to PPAR? at a subset of target genes, leading to epigenomic changes that alter gene transcription. This will be tested by ChIP-seq for coregulators and epigenomic marks in adipocytes treated with TZDs and non-TZD ligands with potentially fewer side effects.
Specific Aim 3 is to understand the mechanisms of cell-type specific genomic binding and regulation by PPAR?. We hypothesize that PPAR? functions as a pioneer factor on some binding sites, particularly in adipocytes, whereas macrophage binding sites are more influenced by cell- specific transcription factors and epigenomic marks. This will be tested using cistromic approaches, and the ability of PPAR? and cell type-specific factors such as PU.1 to shape each other's genomic binding, as well as the adipocyte and macrophage epigenomes, will be explored using gain and loss of function studies. Our innovative approach will elucidate mechanisms underlying target gene- and tissue-specificity of PPAR?, which can be translated to the design of more selective insulin sensitizers to combat the epidemic of metabolic disorders.

Public Health Relevance

The epidemic of type 2 diabetes is related to obesity-related insulin resistance. Drugs that work via the nuclear receptor PPAR?, which regulates gene expression in fat cells, powerfully increase insulin sensitivity but have side effects that limit teir use. These studies will elucidate mechanisms by which PPAR? regulates gene expression, that facilitate the design of safer, more effective insulin sensitizers.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Molecular and Cellular Endocrinology Study Section (MCE)
Program Officer
Margolis, Ronald N
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Soccio, Raymond E; Chen, Eric R; Lazar, Mitchell A (2014) Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab 20:573-91
Lee, Jae Man; Wagner, Martin; Xiao, Rui et al. (2014) Nutrient-sensing nuclear receptors coordinate autophagy. Nature 516:112-5
Step, Sonia E; Lim, Hee-Woong; Marinis, Jill M et al. (2014) Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPAR?-driven enhancers. Genes Dev 28:1018-28
Lefterova, Martina I; Haakonsson, Anders K; Lazar, Mitchell A et al. (2014) PPAR? and the global map of adipogenesis and beyond. Trends Endocrinol Metab 25:293-302
Gardini, Alessandro; Baillat, David; Cesaroni, Matteo et al. (2014) Integrator regulates transcriptional initiation and pause release following activation. Mol Cell 56:128-39
Schupp, Michael; Chen, Fang; Briggs, Erika R et al. (2013) Metabolite and transcriptome analysis during fasting suggest a role for the p53-Ddit4 axis in major metabolic tissues. BMC Genomics 14:758
Everett, Logan J; Lazar, Mitchell A (2013) Cell-specific integration of nuclear receptor function at the genome. Wiley Interdiscip Rev Syst Biol Med 5:615-29
Wang, Fenfen; Mullican, Shannon E; DiSpirito, Joanna R et al. (2013) Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARýý. Proc Natl Acad Sci U S A 110:18656-61
Mullican, Shannon E; Dispirito, Joanna R; Lazar, Mitchell A (2013) The orphan nuclear receptors at their 25-year reunion. J Mol Endocrinol 51:T115-40
Dispirito, Joanna R; Fang, Bin; Wang, Fenfen et al. (2013) Pruning of the adipocyte peroxisome proliferator-activated receptor ? cistrome by hematopoietic master regulator PU.1. Mol Cell Biol 33:3354-64

Showing the most recent 10 out of 52 publications